Tag: EVLA

biolitec

Biolitec announces two new devices in the ELVeS radial portfolio

Biolitec recently announced that it has extended its ELVeS Radial laser system for the minimally invasive laser treatment of insufficient veins by two further...

No long-term advantage of endovenous laser ablation over great saphenous vein...

Ten-year follow-up of a randomised controlled trial (RCT) has shown no clear long-term advantage of endovenous laser ablation (EVLA) with a 980nm wavelength and...

Randomised study compares bare and radial fibres in EVLA

A single-centre, prospective, randomised trial suggests that endovenous laser ablation (EVLA) using a 1470nm laser with a bare fibre (BF) provided outcomes in the...
Johann Chris Ragg and Laser Crossectomy results

EVLA-based study confirms laser crossectomy as superior method of preventing AAGSV...

Laser crossectomy of the GSV has been established as a more effective method of preventing secondary anterior accessory great saphenous vein (AAGSV) reflux than...
Denis-Borsuk-EVLA-UIP

EVLA at different power settings found to have no significant impact...

There is no significant difference in pain and recanalisation for patients undergoing endovenous laser ablation (EVLA) at different power settings, according to the results...

MOCA and EVLA show similar overall pain scores and improvements in...

Data from the LAMA (Laser ablation versus mechanochemical ablation) trial indicate that mechanochemical ablation (MOCA) is significantly less painful than endovenous laser ablation (EVLA)...